AR075295A1 - TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION. - Google Patents
TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION.Info
- Publication number
- AR075295A1 AR075295A1 ARP090104204A AR075295A1 AR 075295 A1 AR075295 A1 AR 075295A1 AR P090104204 A ARP090104204 A AR P090104204A AR 075295 A1 AR075295 A1 AR 075295A1
- Authority
- AR
- Argentina
- Prior art keywords
- approximately
- hemisulfate
- monohidrated
- tianeptine
- asthma
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Reivindicacion 1: 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]ácido heptanoico S,S-dioxido hemisulfato monohidratado, representado por la formula (2). Reivindicacion 2: El 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]ácido heptanoico S,S-dioxido hemisulfato monohidratado, de la reivindicacion 1, en forma cristalina. Reivindicacion 11: El 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]ácido heptanoico S,S-dioxido hemisulfato monohidratado, de la reivindicacion 1, en donde dicho hemisulfato monohidratado se caracteriza por un difractograma de polvo por rayos X que comprende picos a aproximadamente 8,25, aproximadamente 8,97, aproximadamente 11,49, aproximadamente 13,91, aproximadamente 14,73, aproximadamente 16,95, aproximadamente 18,07, aproximadamente 19,39, aproximadamente 20,59, aproximadamente 21,99, aproximadamente 22,83 y aproximadamente 23,27 grados 2-theta.Claim 1: 7 - [(3-chloro-6,11-dihydro-6-methyldibenzo [c, f] [1,2] thiazepin-11-yl) amino] heptanoic acid S, S-dioxide hemisulfate monohydrate, represented by the formula (2). Claim 2: 7 - [(3-Chloro-6,11-dihydro-6-methyldibenzo [c, f] [1,2] thiazepin-11-yl) amino] heptanoic acid S, S-dioxide hemisulfate monohydrate, of claim 1, in crystalline form. Claim 11: 7 - [(3-Chloro-6,11-dihydro-6-methyldibenzo [c, f] [1,2] thiazepin-11-yl) amino] heptanoic acid S, S-dioxide hemisulfate monohydrate, of Claim 1, wherein said monohydrate hemisulfate is characterized by an X-ray powder diffractogram comprising peaks at approximately 8.25, approximately 8.97, approximately 11.49, approximately 13.91, approximately 14.73, approximately 16 , 95, approximately 18.07, approximately 19.39, approximately 20.59, approximately 21.99, approximately 22.83 and approximately 23.27 degrees 2-theta.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11000908P | 2008-10-31 | 2008-10-31 | |
US11000608P | 2008-10-31 | 2008-10-31 | |
US11000108P | 2008-10-31 | 2008-10-31 | |
US22834309P | 2009-07-24 | 2009-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR075295A1 true AR075295A1 (en) | 2011-03-23 |
Family
ID=43447880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090104204 AR075295A1 (en) | 2008-10-31 | 2009-10-30 | TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION. |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR075295A1 (en) |
JO (1) | JO2844B1 (en) |
TW (1) | TWI492937B (en) |
UY (1) | UY32216A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3758528A (en) * | 1970-03-13 | 1973-09-11 | Science Union & Cie | Tricyclic compounds |
FR2791891A1 (en) * | 1999-04-07 | 2000-10-13 | Adir | USE OF TIANEPTINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF NEURODEGENERESCENCE CONDITIONS |
-
2009
- 2009-10-29 JO JO2009398A patent/JO2844B1/en active
- 2009-10-30 AR ARP090104204 patent/AR075295A1/en unknown
- 2009-10-30 TW TW098136937A patent/TWI492937B/en not_active IP Right Cessation
- 2009-10-30 UY UY32216A patent/UY32216A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JO2844B1 (en) | 2014-09-15 |
TW201029981A (en) | 2010-08-16 |
TWI492937B (en) | 2015-07-21 |
UY32216A (en) | 2010-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR068369A1 (en) | N4 XINAFOATE SALT - [(2,2-DIFLUOR-4H-BENZO [1,4] OXAZIN-3-ON) -6-IL] -5-FLUOR-N2- [3- (METHYLAMINOCARBONYLMETHYLENE) -FENYL] 2 , 4-PYRIMIDINDIAMINE " | |
UY32648A (en) | NEW DERIVATIVES OF PYRIMIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
CL2007001166A1 (en) | Compounds derived from condensed pyrimidine, pi3-kinase inhibitors; processes to prepare the compounds; pharmaceutical composition that includes them; use of the compounds in the preparation of medicaments; process to prepare the pharmaceutical composition; and kit that includes the pharmaceutical composition | |
EA201100969A1 (en) | SALT FORMS OF ORGANIC COMPOUND | |
ECSP10010346A (en) | 3H- [1,2,3] TRIAZOLO [4,5-D] PIRIMIDINE COMPOUNDS, THEIR USE AS INHIBITORS OF MTOR QUINASA AND PI3 QUINASA AND THEIR SYNTHESIS | |
PE20070845A1 (en) | PYRAZOLO [1,5-ALPHA] PYRIMIDIN DERIVATIVES USEFUL AS ANTAGONIST RECEPTORS OF CORTICOTROPIN RELEASE FACTOR (CRF) | |
ECSP11011151A (en) | PURINE COMPOUNDS | |
CL2011002115A1 (en) | Compounds derived from 5-phenyl-1h-pyridin-2-one and 5-phenyl-pyrazin-2-one, bruton tyrosine kinase inhibitors (btk); process of preparation of the compounds, intermediate compound, pharmaceutical composition and use in the treatment of inflammatory and / or autoimmune diseases. | |
CL2008003181A1 (en) | 3- [5- (Pyridin-2-yl-methoxy) -3- (2-methyl-2-propylthio) -1- [4- (2-methoxypyridin-5-yl) benzyl] -indol-2 acid salt -yl] -2,2-dimethyl-propionic; crystallin from sodium salt; Preparation process; pharmaceutical compositions; pharmaceutical kit, and use for the treatment of asthma. | |
UY33337A (en) | SUBSTITUTED DERIVATIVES OF 1H-PIRAZOL [3,4-d] PYRIMIDINE AS INHIBITORS OF PHOSFOINOSITIDE 3-KINASES | |
CL2008000946A1 (en) | COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES | |
CO6690744A2 (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
MX2009005048A (en) | New process for the preparation of 2-imino-thiazolidin-4-one derivatives. | |
GT201200158A (en) | PROCEDURE FOR THE PREPARATION OF {4,6-DIAMINO-2- [1- (2-FLUOROBENCIL) -1H-PIRAZOLO [3,4-B] PIRIDIN-3-IL] PIRIMIDIN-5-IL} METHYL CARBAMATE AND ITS PURIFICATION FOR USE AS A PHARMACEUTICAL ACTIVE PRINCIPLE | |
CL2012000708A1 (en) | Compounds derived from imidazopyridine or imidazopyrimidine, inhibitors of pde10a; process of preparation of said compounds; pharmaceutical compositions; and its use for the therapeutic and / or preventive treatment of psychotic disorders, schizophrenia, Alzheimer's disease, solid tumors, among other diseases. | |
UY28896A1 (en) | POWDER FORMULATIONS FOR INHALATION, WHICH CONTAIN BETA-ENANTIOMERALLY PURE AGONISTS | |
TW200745122A (en) | New compounds I | |
CU23889B1 (en) | 5 - [(3,3,3-TRIFLUORO-2-HIDROXI-1-ARILPROPIL) AMINO] -1H-QUINOLIN-2-ONAS, A PROCESS FOR ITS PRODUCTION AND ITS USE AS ANTINFLAMATORY AGENTS | |
TW200730511A (en) | Chroman compounds | |
BRPI0408353A (en) | compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound | |
JO2682B1 (en) | 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof | |
MX2012005225A (en) | N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use. | |
AR116001A2 (en) | PHARMACEUTICAL COMPOSITION 271 | |
CU20120081A7 (en) | NEW POLYMORPH FORMS OF {4,6-DIAMINO-2- [1- (2-FLUOROBENCIL) -1H-PIRAZOLO [3,4-B] PIRIDIN-3-IL] PIRIMIDIN-5-IL} CARBAMATO DE METTILO | |
BR112013017757A2 (en) | crystalline oxazine derivative and its use as a bace inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |